-
-
Hello, Thailand! Fosun Diagnostics Wows Medlab Asia 2023 with Blockbuster Products
2023-08-29
From August 16 to 18, Medlab Asia 2023 was staged in Bangkok, Thailand.As the most influential exhibition for clinical laboratory medicine in Asia, this year's Medlab Asia brought together 350-plus exhibitors from more than 50 countries and regions and at least 7,500 professional visitors, providing a unique platform for medical and laboratory
-
-
Fosun International Wins Pioneering Award for ESG Disclosure Contribution at the HKQAA Hong Kong Green and Sustainability Contribution Awards 2023
2023-08-28
(28 August 2023, Hong Kong) Hong Kong Quality Assurance Agency (“HKQAA”) held the Hong Kong Green and Sustainability Contribution Awards 2023on 25 August. Fosun International was awarded the Pioneering Award for ESG Disclosure Contributionby HKQAA, in recognition of the company's performance in environmental, social, governance and sustainable development
-
-
Fosun Tourism Announces 2023 Interim Results: Revenue Increases by nearly 40%, Turning Losses into Profits
2023-08-28
Results Highlights:Business Volume of the Group’s tourism operation increased by 29.0% year-on-year to RMB9,488.0 million, while revenue grew by 38.7% to RMB8,898.8 million.Losses were turned into profits, achieving a net profit attributable to equity holders of the Company of RMB471.8 million.Club Med'sBusiness Volumesurpassed pre-pandemic levels, with strong growth
-
-
Henlius 2023 H1 Results: Achieved record profits and RMB2.5 billion revenues, opening a new chapter of high-quality growth
2023-08-25
Shanghai, China, August 25th, 2023 - Henlius (2696.HK) announced its 2023 interim results.In the first half of 2023, Henlius reported a boost in operating profits of RMB240.0 million and revenues of RMB2.5005 billion, up by 93.9% YoY, driven by growth in core oncology products.HANQUYOU (trastuzumab) and HANSIZHUANG (anti-PD-1 mAb) recorded sales of RM
-
-
Sisram Medical Announces First-Half 2023 Financial Results
2023-08-23
Expanding Sisram's Ecosystem Offerings and Increasing Direct Sales ReachHONG KONG,Aug. 23, 2023/PRNewswire/ -- Sisram Medical Ltd (the "Company"or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a distinguished synergistic ecosystem of business build
-
-
Fosun International Awarded “ESG Achievement Programme 2023” Logo and Certificate of Appreciation by Hong Kong Economic Journal
2023-08-21
(21 August 2023, Hong Kong) Hong Kong’s first Chinese financial newspaper, Hong Kong Economic Journal (HKEJ) announced the list of companies with outstanding ESG performance on 18 August. Fosun International was awarded the “ESG Achievement Programme 2023” logo and certificate of appreciation by HKEJ, in recognition of the company's performance in environmental,
-
-
Focusing on Empowering Businesses Through Public Welfare, Fudan ESG iLAb Business Challenge Successfully Concludes
2023-08-20
On 20 August 2023, the final of the Fudan MBA iLab Business Challenge was held in AIA Hall, School of Management, Fudan University. This year's challenge was centered around two major themes: technology innovation and ESG (environmental, social and governance). On the social front of ESG, Fosun Foundation proposed the research topic of "empowering
-
-
Henlius Announces Upcoming Oral Presentation at WCLC 2023 Featuring Results for HANSIZHUANG from a Phase 3 MRCT in sqNSCLC
2023-08-18
From September 9-12, 2023, the IASLC 2023 World Conference on Lung Cancer (“WCLC 2023”) hosted by the International Association for the Study of Lung Cancer will be held in Singapore. Results of the final analysis of efficacy, including progression-free survival (PFS) and overall survival (OS), and safety from the pivotal ASTRUM-004 study of HANSIZHUANG (serp
-
-
After 12 Rounds of Chemotherapy, CAR-T Cell Therapy Finally Cures Her of Lymphoma
2023-08-09
Source: Xinmin Evening NewsSpeaking of the most popular cancer treatment in recent years, chimeric antigen receptor T cell (CAR-T) in immunotherapy is definitely one of the focus areas. Since its launch in China, has CAR-T cell therapy helped patients achieve long-term survival? What does it mean for CAR-T cell therapy to be approved for use as a second-line treatment? At the 3rd China